Actively Recruiting
Evaluation of kTMP Brain Stimulation for Upper Limb Rehabilitation After Chronic Stroke
Led by Magnetic Tides · Updated on 2026-09-29
6
Participants Needed
1
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating kilohertz transcutaneous magnetic perturbations kTMP, a low intensity transcranial magnetic stimulation device, to promote arm and hand recovery in patients disabled by chronic stroke. This pilot clinical trial aims to assess both the feasibility and early effectiveness of kTMP compared to a sham treatment on improving upper limb motor function. The study is a double-blind, randomized, sham-controlled trial lasting six weeks, focusing on movement quality and other motor outcomes. Participants are randomly assigned to receive either active kTMP stimulation or sham stimulation. The active group will receive 8 Vm of stimulation three times per week for six weeks, while the control group receives a sham device with no electric field. The treatment begins within one week after randomization. Follow-up assessments occur at the end of treatment and at 1, 3, and 6 months post-treatment. An additional evaluation is performed four weeks into the treatment to assess ongoing improvements. Throughout the study, participants undergo multiple assessments including the Movement Quality Index and Fugl-Meyer Assessment, among others, at baseline, during treatment, and at follow-up intervals. Motor function, spasticity, quality of life, and stroke impact are measured. Participants are monitored for safety and adherence, with the primary outcome focused on movement quality. Total participation spans over six months including treatment and follow-up periods.
CONDITIONS
Brief Title
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
Research Team
L
Ludovica Labruna, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here